Skip to main content

The “Bispecific Antibody Therapeutics Market (4th Edition), 2019-2030” report

 

To order this detailed 370+ page report, please visit this - https://www.rootsanalysis.com/reports/view_document/bispecific-antibodies/286.html

 

Key Inclusions

§  A detailed review of the overall landscape of bispecific antibody therapeutics, including information on drug developers, phase of development (marketed, clinical, and preclinical / discovery) of the pipeline candidates, target antigen, type of antibody format, mechanism of action, target disease indication(s), therapeutic area, broader disease segment, route of administration, mode of administration and patient segment. 

§  A comprehensive list of novel technology platforms that are either currently available or being developed by various firms for the generation of bispecific antibody therapeutics, along with detailed profiles of key technologies. The chapter also includes an insightful competitiveness analysis, featuring a three-dimensional bubble representation that highlights the key technologies that are being used for the development of bispecific antibodies, taking into consideration the early stage (discovery, preclinical, IND and phase I)  and late stage (phase II and above) development activity based on the technology (in terms of the number of drugs across different phases of development), number of partnerships established related to the technology and size of the developer company. In addition, it consists of a schematic world map representation, highlighting the geographical locations of technology developers engaged in this domain.

§  Detailed profiles of marketed and clinical stage (phase II and phase III) bispecific antibody therapeutics. Each profile features an overview of the drug, details of the developer, along with its financial performance, mechanism of action and targets, dosage information, current clinical development

§  A clinical trial analysis of ongoing and planned studies related to bispecific antibody therapeutics, taking into consideration a number of relevant parameters, including trial registration year, trial recruitment status, trial phase, trial design, disease indication(s), focus therapeutic area, most active industrial and non-industrial players, and geographical location of the trial.

 

The report also features the likely distribution of the current and forecasted opportunity across important market segments, mentioned below:

  • Therapeutic Area 

§  Autoimmune Disorders

§  Eye Disorders

§  Genetic Disorders

§  Hematological Malignancies

§  Infectious Diseases

§  Inflammatory Disorders

§  Skin Disorders 

 

  • Mechanism of Action

§  Cytokines Retargeting / Neutralization

§  Dual Ligands Blocking

§  T-cell Retargeting / Activation

§  Others

 

  • Target Antigens

§  CD3 x CD19

§  CD30 x CD16A

§  Factor IXa x Factor X

§  IL-1α x IL-1β

§  IL-13 x IL-4

To request sample pages, please visit this - https://www.rootsanalysis.com/reports/286/request-sample.html

 

Key Questions Answered

§  What are the key technologies used for the development of bispecific antibodies?

§  What are the key biological target combinations and antibody formats that are being explored for bispecific antibody development?

§  Who are the leading industry and non-industry players engaged in this market?

§  What kind of partnership models are commonly adopted by bispecific antibody developers?

§  Which CMOs offer services for manufacturing bispecific antibodies?

§  What are the regulatory guidelines issued by different organizations related to the development of bispecific antibodies?

§  What kind of promotional strategies are being used by developers of marketed bispecific antibody developers?

§  How is the current and future market opportunity (related to bispecific antibodies) likely to be distributed across key market segments?

 

You may also be interested in the following titles:

1.     Global Preventive Vaccines Market, 2020-2030

2.     Endocannabinoid System Targeted Therapeutics Market, 2019-2030

3.     Antibody Contract Manufacturing Market, 2020-2030

 

About Roots Analysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com

 

Contact Information

Roots Analysis Private Limited

Gaurav Chaudhary

+1 (415) 800 3415

ben.johnson@rootsanalysis.com

Facebook - https://www.facebook.com/RootsAnalysis

LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/

Twitter - https://twitter.com/RootsAnalysis

 

 

Labels:

Comments

Post a Comment

Popular posts from this blog

Manufacturing Market Continuous by Roots Analysis

    Recent advances in the manufacturing technologies have prompted pharmaceutical companies to consider shifting from the traditional multi-step, batch manufacturing processes to faster, and relatively more efficient continuous manufacturing   Roots Analysis is pleased to announce the publication of its recent study, titled, “ Manufacturing Market Continuous (Small Molecules and Biologics), 2020 – 2030 .”   The report features an extensive study of the current market landscape and future opportunities for companies with capabilities in continuous manufacturing (both innovator companies with in-house expertise and contract manufacturers). It features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. In addition to other elements, the study includes: §   A detailed assessment of the overall landscape of companies with capabilities for continuous manufacturing §   Elaborate profiles of some o...
Post a Comment
Read more

The Alzheimer’s disease market is anticipated to grow at an annualized rate of over 13%, till 2030, claims Roots Analysis

  Roots Analysis has announced the addition of “ Alzheimer's Disease Market (2 nd Edition), 2021-2031 ” report to its list of offerings.   Limited treatment options and unmet needs are the key drivers of research activity in this domain. Several industry and non-industry players are presently engaged in developing various types of disease modifying interventions and drug / therapy candidates that offer symptomatic relief. Moreover, multiple venture capital firms and other strategic investors have been supporting the research related initiatives of various start-ups. Driven by a rich development pipeline and the efforts of various stakeholders, the market is anticipated to grow at a significant pace in the coming future.   To order this 150+ page report, which features 90+ figures, please visit https://www.rootsanalysis.com/reports/view_document/alzheimers-disease-market/247.html   Key Market Insights   More than 240 drug candidates for the t...
Post a Comment
Read more

Continuous Manufacturing Market (Small Molecules and Biologics) by Roots Analysis

  To order this 310+ page report, which features 110+ figures and 200+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/continuous-manufacturing/308.html   Key Inclusions §   A detailed assessment of the overall landscape of companies with capabilities for continuous manufacturing, along with information on a number of relevant parameters, such as year of establishment, company size, purpose of manufacturing (in-house and contract services), scale of operation (preclinical, clinical and commercial), location of headquarters, location of manufacturing facilities, type of drug molecule (biologic and small molecule), type of continuous manufacturing related service(s) offered (process development, API manufacturing, intermediate manufacturing, drug product manufacturing, and packaging and fill / finish),   type of dosage form (solid and liquid), and installed capacity and batch size (if available). §   Elaborate profiles of so...
Post a Comment
Read more